Tuesday, June 2, 2020

Strides Pharma gets USFDA nod for generic ointment to treat skin conditions

Strides Pharma gets USFDA nod for generic ointment to treat skin conditions The approval is granted to the company#39;s step-down wholly owned subsidiary, Strides Pharma Global, Singapore, by the United States Food and Drug Administration (USFDA) for triamcinolone acetonide ointment USP, 0.05 per cent, Strides Pharma Science said in a regulatory filing.

from Moneycontrol Business News https://ift.tt/2Att3Ib
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

Largecap valuations near fair value, time to start deploying: Jyotivardhan Jaipuria

​So, banks are cheap. And second is, at these valuations, a lot of bad news is priced in. So, as we see growth coming back, as we see things...